FI810509L - Hetero-iminoprostacykliner - Google Patents

Hetero-iminoprostacykliner

Info

Publication number
FI810509L
FI810509L FI810509A FI810509A FI810509L FI 810509 L FI810509 L FI 810509L FI 810509 A FI810509 A FI 810509A FI 810509 A FI810509 A FI 810509A FI 810509 L FI810509 L FI 810509L
Authority
FI
Finland
Prior art keywords
treatment
methods
pgi2
analogs
iminoprostacykliner
Prior art date
Application number
FI810509A
Other languages
English (en)
Inventor
Gerhard Beck
Jochen Knolle
Richard Helmut Rupp
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI810509L publication Critical patent/FI810509L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
FI810509A 1980-02-23 1981-02-19 Hetero-iminoprostacykliner FI810509L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803006865 DE3006865A1 (de) 1980-02-23 1980-02-23 Hetero-imino-prostacycline

Publications (1)

Publication Number Publication Date
FI810509L true FI810509L (fi) 1981-08-24

Family

ID=6095414

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810509A FI810509L (fi) 1980-02-23 1981-02-19 Hetero-iminoprostacykliner

Country Status (17)

Country Link
US (1) US4371542A (fi)
EP (1) EP0034778B1 (fi)
JP (1) JPS56133265A (fi)
AT (1) ATE7225T1 (fi)
AU (1) AU545358B2 (fi)
CA (1) CA1198106A (fi)
DE (2) DE3006865A1 (fi)
DK (1) DK157852C (fi)
ES (2) ES499484A0 (fi)
FI (1) FI810509L (fi)
HU (1) HU187318B (fi)
IE (1) IE50957B1 (fi)
IL (1) IL62197A (fi)
MX (1) MX6834E (fi)
NZ (1) NZ196316A (fi)
PH (1) PH21973A (fi)
ZA (1) ZA811146B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946756A1 (de) * 1979-11-20 1981-05-27 Hoechst Ag, 6000 Frankfurt Stickstoff-haltige prostaglandin/prostacyclin-synthone und verfahren zu ihrer herstellung
DE3100083A1 (de) * 1981-01-03 1982-08-05 Hoechst Ag, 6000 Frankfurt "11-desoxy-hetero-imino-prostacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel"
EP0063538B1 (de) * 1981-04-13 1986-08-06 Schering Aktiengesellschaft Neue Prostaglandine und Prostacycline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3117979A1 (de) * 1981-05-07 1983-01-20 Hoechst Ag, 6000 Frankfurt Neue(delta)1-pyrrolin-thiolactimaether und verfahren zu ihrer herstellung
JPS6028943A (ja) * 1983-07-26 1985-02-14 Sankyo Co Ltd カルバサイクリン類縁体
JPS60181041A (ja) * 1984-02-29 1985-09-14 Sankyo Co Ltd カルバサイクリン誘導体
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
US5221689A (en) * 1984-07-23 1993-06-22 Ono Pharmaceutical Co., Ltd. Prostaglandin analogues, processes for their preparation and pharmaceutical compositions containing them
CA1284642C (en) * 1986-03-31 1991-06-04 Hikozo Iwakura Prostacyclin (pgi ) analogues
DE68904358T2 (de) * 1988-06-17 1993-07-29 Wellcome Found Prostaglandinanaloge zur verwendung in der medizin.
EP2484655A1 (en) * 2011-02-04 2012-08-08 Vironova AB A thionation process and a thionating agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097489A (en) * 1977-06-17 1978-06-27 The Upjohn Company 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent

Also Published As

Publication number Publication date
MX6834E (es) 1986-08-15
JPH032860B2 (fi) 1991-01-17
EP0034778A1 (de) 1981-09-02
AU6750981A (en) 1981-09-03
IL62197A0 (en) 1981-03-31
CA1198106A (en) 1985-12-17
DK78181A (da) 1981-08-24
ES8206473A1 (es) 1982-08-16
ATE7225T1 (de) 1984-05-15
ES499484A0 (es) 1982-08-16
PH21973A (en) 1988-05-02
AU545358B2 (en) 1985-07-11
IL62197A (en) 1986-09-30
IE50957B1 (en) 1986-08-20
DK157852B (da) 1990-02-26
JPS56133265A (en) 1981-10-19
ZA811146B (en) 1982-03-31
DE3006865A1 (de) 1981-09-10
ES8301212A1 (es) 1982-11-16
IE810349L (en) 1981-08-23
ES509176A0 (es) 1982-11-16
US4371542A (en) 1983-02-01
HU187318B (en) 1985-12-28
NZ196316A (en) 1984-08-24
DK157852C (da) 1990-07-30
DE3163263D1 (en) 1984-05-30
EP0034778B1 (de) 1984-04-25

Similar Documents

Publication Publication Date Title
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO155133C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme dicykliske forbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
FI810509L (fi) Hetero-iminoprostacykliner
NO164473C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-pyridylmethyl-thio- og -sulfinylbenzimidazoler.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO874892D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger.
FI863565A (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
IT8319999A0 (it) Procedimento di trattamento dei gas di scarico.
SE7910554L (sv) Disulfidforeningar
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
SE7603223L (sv) 13,14-dehydro-11-deoxi-prostaglandiner och forfarande for deras framstellning
NO163896C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner.
IT8220803A0 (it) Procedimento per la preparazione del 2,3-diidro-2,2-dimetilbenzofuran-7olo.
NO153295C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(aryloxyalkyl)-n`-(aminoalkyl)-ureaderivater.
IT7949563A0 (it) Procedimento di stabilizzazione del tricloro-1,1,1 etano
FI853868A0 (fi) Pyridinderivat, foerfarande foer framstaellning av dessa och farmaceutiska foereningar innehaollande dessa.
NO154965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolderivater.
NO160139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive akridanonderivater.
NO884635L (no) Fremgangsmaate for behandling av voerter.
NO154696C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte difenylazometinderivater.
FI77023B (fi) Foerfarande foer framstaellning av 1-alkyl- eller 1,4-dialkyl-1h-pyrrol-2-aettiksyraestrar.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT